Causation

SARS-CoV-2 UK Variant Response to mRNA Vaccine

The UK B.1.1.7 SARS-CoV-2 variant was tested against the Moderna mRNA-1273 vaccine. The B.1.1.7 variant had no significant impact on the neutralizing capacity of vaccinated serum, and the N501Y mutation tested alone also showed no significant effect. mRNA-1273 neutralized the B.1.1.7 variant to the same extent as the D614G wild-type strain, indicating mRNA vaccines remain effective against the B.1.1.7 variant.

0

1

Updated 2026-07-10

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences